DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Stock Has Consensus Target Price of $12.92 According to Analysts

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) have been given an average rating of “Hold” by the fourteen ratings firms that are currently covering the company, Marketbeat reports. Three equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and three have given a buy rating to the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is $12.77.

A number of brokerages recently issued reports on XRAY. Weiss Ratings reiterated a “sell (e+)” rating on shares of DENTSPLY SIRONA in a research report on Monday, August 3rd. Mizuho reduced their price target on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating on the stock in a research report on Thursday. Barclays boosted their price target on shares of DENTSPLY SIRONA from $9.00 to $11.00 and gave the company an “underweight” rating in a research report on Monday, August 24th. Piper Sandler decreased their price objective on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating on the stock in a research note on Friday, October 9th. Finally, BMO Capital Markets dropped their price objective on shares of DENTSPLY SIRONA from $13.00 to $10.00 and set a “market perform” rating for the company in a report on Thursday, September 17th.

DENTSPLY SIRONA Stock Performance

Shares of NASDAQ:XRAY opened at $9.43 on Thursday. The company has a debt-to-equity ratio of 1.48, a current ratio of 1.63 and a quick ratio of 1.07. The business’s fifty day moving average price is $9.87 and its two-hundred day moving average price is $10.95. DENTSPLY SIRONA has a fifty-two week low of $8.32 and a fifty-two week high of $14.76. The stock has a market capitalization of $1.88 billion, a price-to-earnings ratio of -3.43, a price-to-earnings-growth ratio of 1.20 and a beta of 0.87.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings data on Thursday, August 6th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.35 by $0.17. DENTSPLY SIRONA had a positive return on equity of 20.84% and a negative net margin of 14.99%. The company had revenue of $898.00 million during the quarter, compared to analysts’ expectations of $889.93 million. During the same period last year, the business earned $0.52 earnings per share. The business’s revenue was down 4.1% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. As a group, analysts predict that DENTSPLY SIRONA will post 1.39 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of XRAY. Paradigm Capital Management Inc. NY bought a new position in DENTSPLY SIRONA in the 2nd quarter valued at $39,775,000. BlackRock Inc. acquired a new position in DENTSPLY SIRONA in the second quarter worth $283,405,000. The Manufacturers Life Insurance Company acquired a new position in DENTSPLY SIRONA in the second quarter worth $1,956,000. Bank of New York Mellon Corp acquired a new position in DENTSPLY SIRONA in the second quarter worth $16,408,000. Finally, Edmond DE Rothschild Holding S.A. acquired a new position in DENTSPLY SIRONA in the second quarter worth $47,780,000. 95.70% of the stock is owned by institutional investors and hedge funds.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA is a global manufacturer of professional dental products and technologies. The company serves dentists, dental specialists, dental laboratories and other oral health professionals with solutions used in preventive, restorative, prosthetic, endodontic and implant dentistry.

Its portfolio includes dental equipment, imaging and treatment systems, CAD/CAM technology, consumable dental materials, orthodontic products, endodontic instruments and solutions, dental implants, prosthetic components and laboratory products.